Hypertension
Researchers from Children's Hospital publish new studies and findings in the area of hypertension in children
Published in Drug Law Weekly, April 3rd, 2007
New investigation results, "Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil," are detailed in a study published in American Journal of Cardiology. According to a study from the United States, "Intravenous epoprostenol was the first agent approved by the United States Food and Drug Administration for the management of pulmonary arterial hypertension (PAH). However, epoprostenol therapy carries the risks of a short half-life (<6 minutes) and side effects, including jaw pain, flushing, and headache."
"Recently, intravenous treprostinil has been studied, primarily in adults with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-04-03)
More Articles from Drug Law Weekly
- Alcoholism
New alcoholism study findings recently were published by researchers at RTI International - Cancer Vaccines
Geron Corporation Reports Fourth Quarter And Annual 2006 Financial Results And Highlights - Cancer Vaccines
IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percent in 2006, to $643 Billion - Drug Development
Teva Provides Update on Generic Celebrex Litigation - Drug Resistance
Studies from University of Chicago reveal new findings on drug resistance - DUSA Pharmaceuticals
Dusa Pharmaceuticals Reports Fourth-quarter And Year-end 2006 Financial Results - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
